XENON XE 133
LOE ApproachingNDAINHALATIONGAS
Approved
Nov 1976
Lifecycle
LOE Approaching
Competitive Pressure
30/100
Data completeness
1/8 — Limited
Drug data last refreshed 5h ago · AI intelligence enriched 1w ago
AI summarySynthesized from FDA + DailyMed + ClinicalTrials.gov data
Xenon Xe 133 is an inhaled radioactive gas used as a diagnostic imaging agent for pulmonary ventilation studies. It enables visualization of lung function and airflow patterns in patients with suspected respiratory disease. The drug works by inhalation, allowing real-time assessment of ventilation distribution across lung tissue.
LOE Approaching
As an aging diagnostic gas with approaching loss of exclusivity and low competitive pressure (30%), career growth on this brand is limited; team restructuring and consolidation are likely.
Mechanism of Action
Mechanism of action data is being enriched from DailyMed and FDA sources. Check back soon for updated drug intelligence.
Indications
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Career Relevance
Zero linked job openings signal declining organizational investment in this product line. Working on Xenon Xe 133 offers limited career visibility and growth—this is a legacy portfolio hold rather than a career-building opportunity.
Product Manager (Diagnostics)Regional Sales Manager
Worked on XENON XE 133 at GE HealthCare? Share your interview experience or compensation data (+7 days Pro)
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.